Please assess the completion status of the following clinical trial:

Trial Title: Intermittent Pneumatic Compression Device for Vein Dilation in Kidney Disease Patients to Enable AVF Creation (FACT)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18 and older~* Followed in the University of Chicago Medical Center's Nephrology Clinic~* Expected to initiate hemodialysis~* Estimated Glomerular Filtration Rate (eGFR) \<30 mL/min.1.73m~Exclusion criteria:~* Refusal/inability to give informed consent~* Inability to comply with trial requirements,~* Arm infections and/or skin disorders that require frequent medical attention.~* Patients with obvious scarring from IV drug use~* Previous phlebitis.~* Previous occluded arteriovenous grafts or fistulae~* Arterial aneurysms~* Arm deep vein thrombosis~* Any previous vascular surgery on the non-dominant arm.~* Limited cognitive ability~* Motor or sensory deficits in the upper arm~* Upon preliminary evaluation of the cephalic vein (measured 5 cm proximal to the styloid process of the radius, and at the antecubital fossa) there are no detectable superficial veins of at least 1.0 mm diameter, or superficial vein of more than 3.0 mm is present in this lower arm location.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fist Assist device (all subjects) (Type: EXPERIMENTAL): All study subjects will have Stage 4 or 5 Chronic Kidney Disease (CKD) that requires them to start hemodialysis. In preparation for hemodialysis, they will have an arteriovenous fistula (AVF) procedure which provides access to the veins for dialysis.~This study is testing a device called the Fist Assist to dilate the vein in preparation for dialysis. The device is similar to a blood pressure cuff (worn around the arm and applies pressure). All study participants will wear the Fist Assist twice a day up to three months before their AVF procedure.

Based on this trial design, predict the completion outcome and termination type (if applicable).